TGA Approval

ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection flange extender (177176)

ARTG ID

177176

ARTG Name

ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection flange extender

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

January 4, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03513-3

Ingredient Name

Abatacept

Empowering clinical research with data-driven insights and AI-powered tools.

ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection flange extender (177176) - TGA 批准文号 | MedPath